Michael Detke

Safety and PK data from the Phase I trial of COR588

GAIN trial: evidence of target engagement and activity with atuzaginstat in Alzheimer’s disease

Phase II/III GAIN trial results: atuzaginstat for disease modification in Alzheimer’s disease

Developing gingipain inhibitors for the treatment of Alzheimer’s disease

COR388: a novel approach to treating Alzheimer’s based on the gingipain hypothesis

Targeting P. gingivalis infection to treat Alzheimer’s: the evidence

Phase II/III GAIN trial of a novel lysine-gingipain inhibitor for the treatment of Alzheimer’s